Key result
Chronic iVDPV2 infections drive accelerated capsid evolution in immunodeficient hosts, posing ongoing outbreak risks.
Why the study?
Outbreaks of type 2 circulating vaccine-derived polioviruses are increasing, and patients with primary immunodeficiency diseases carry higher risks for long-term immunodeficiency-associated infections that threaten global polio eradication.
Highlights the potential risk of inapparent immunodeficiency-associated vaccine-derived poliovirus (iVDPV) infection for expanding circulating vaccine-derived poliovirus outbreaks.
The oral poliovirus vaccine (OPV), which prevents person-to-person transmission of poliovirus by inducing robust intestinal immunity, has been a crucial tool for global polio eradication. However, polio outbreaks, mainly caused by type 2 circulating vaccine-derived poliovirus (cVDPV2), are increasing worldwide. Meanwhile, immunodeficiency-associated vaccine-derived poliovirus (iVDPV) is considered another risk factor during the final stage of global polio eradication. Patients with primary immunodeficiency diseases are associated with higher risks for long-term iVDPV infections. Although a limited number of chronic iVDPV excretors were reported, the recent identification of a chronic type 2 iVDPV (iVDPV2) excretor in the Philippines highlights the potential risk of inapparent iVDPV infection for expanding cVDPV outbreaks. Further research on the genetic characterizations and molecular evolution of iVDPV2, based on comprehensive iVDPV surveillance, will be critical for elucidating the remaining risk of iVDPV2 during the post-OPV era.
No takes yet. Share an insight, caveat, or question.
Kitamura et al. (2021) conducted a review in Immunodeficiency-associated vaccine-derived poliovirus (iVDPV) infection in primary immunodeficiency diseases (n=19). Type 2 oral poliovirus vaccine (OPV2) and subsequent chronic iVDPV2 infection vs. Infection with circulating vaccine-derived poliovirus (cVDPV) or wild-type poliovirus was evaluated. Chronic iVDPV2 infections in immunodeficient individuals undergo rapid molecular evolution with higher rates of non-synonymous substitutions in capsid proteins compared to circulating strains, representing a persistent risk for future polio outbreaks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: